IDEAYA Biosciences Initiates First Patient Enrollment in Innovative Phase 1 Combination Clinical Study IDEAYA Biosciences announces the commencement of their Phase 1 clinical trial combining IDE849 and IDE161 for treating various solid tumors, including SCLC and melanoma.

IDEAYA Biosciences Initiates First Patient Enrollment in Innovative Phase 1 Combination Clinical Study #United_States #IDEAYA_Biosciences #South_San_Francisco #IDE161 #IDE849

IDEAYA Begins Phase 1 Trial for IDE161 with KEYTRUDA in Endometrial Cancer Patients IDEAYA Biosciences has initiated a Phase 1 clinical trial assessing the safety and efficacy of its investigational drug IDE161 with KEYTRUDA. This trial will focus on endometrial cancer patients.

IDEAYA Begins Phase 1 Trial for IDE161 with KEYTRUDA in Endometrial Cancer Patients #USA #IDEAYA_Biosciences #South_San_Francisco #IDE161 #KEYTRUDA